Latest Pharmaceutical News
Innate Immune Grants Cephalon Australia License To Develop Antibodies For Asthma, SLE
Innate Immune, a privately held biotechnology company, has granted Cephalon Australia an exclusive license to develop antibodies for the treatment of asthma and systemic lupus erythematosis (SLE). Cephalon Australia is a wholly owned subsidiary of Cephalon Inc.
Published: 16-Mar-2010
Eli Lilly To Acquire Worldwode License For Acrux Testosterone Solution Axiron
Eli Lilly and Acrux have entered into an exclusive worldwide license agreement for the potential commercialisation of Acrux's experimental underarm testosterone solution (proposed tradename Axiron).
Published: 16-Mar-2010
Sigma-Aldrich To Sell Pfizer Bioactive Small Molecule Compounds
Sigma-Aldrich has entered into an agreement with Pfizer to sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterisation, assay development, screening and in-vivo animal model applications.
Published: 15-Mar-2010
Lee's Pharma, Recordati Enter Into License Agreement For Zanidip Tablets
Lee's Pharmaceutical and Recordati, a European pharmaceutical group, have entered into a license and supply agreement for Recordati's original product Zanidip (lercanidipine) in China. The agreement grants Lee's pharma an exclusive license to market and sell Zanidip (lercanidipine tablets) for the treatment of hypertension in the People's Republic of China.
Published: 15-Mar-2010
AspenBio Pharma Signs AppyScore Cassette Development, Supply Agreement With BBInternational
AspenBio Pharma, a bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, has entered into a strategic manufacturing relationship with BBInternational (BBI) to complete commercial development and manufacture of the AppyScore consumable test cassette.
Published: 11-Mar-2010
Unilife, Stason Pharma Sign Agreement For Unitract 1mL Safety Syringe
Unilife Corp has signed an exclusive five-year agreement with Stason Pharma to market Unitract 1mL safety syringe in Japan, China and Taiwan. Stason's Taiwan-based strategic alliance affiliate Standard Chem and Pharm, will act as the primary distributor of the product within these designated territories.
Published: 11-Mar-2010
Azur Pharma To Acquire Analgesic Therapy From Elan
Azur Pharma (Azur) has entered into an agreement with Elan Pharmaceuticals to acquire worldwide rights, excluding Europe, of Elan's analgesic therapy Prialt (ziconotide intrathecal infusion), used for pain relieving.
Published: 11-Mar-2010
Affymax Receives Milestone Payment For Phase 3 Clinical Trials Of Hematide
Affymax has received a $5m development milestone payment from Takeda Pharma as part of its exclusive global agreement to develop and commercialize investigational drug Hematide for the treatment of anemia in chronic renal failure patients.
Published: 10-Mar-2010
Spear Group Renews Contract With Pharma Company
Spear Group, a provider of project controls and project management services in the US and Puerto Rico, has renewed professional services contract with a major pharmaceutical manufacturing company.
Published: 10-Mar-2010
ZenBio Licenses 3T3-L1 Cell Line From Harvard To Propel Metabolic Disease Research
ZenBio, a privately held biotechnology company and provider of research tools for the study of human metabolic disease, has said that it will be a commercial source for the murine 3T3-L1 cell line, which has been elementary in metabolic disease research for years.
Published: 10-Mar-2010
